These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 11331441)

  • 1. Bivalirudin (Angiomax) for angioplasty.
    Med Lett Drugs Ther; 2001 Apr; 43(1103):37-8. PubMed ID: 11331441
    [No Abstract]   [Full Text] [Related]  

  • 2. Thrombin inhibitor approved for anticoagulation during angioplasty.
    Lieder TR
    Am J Health Syst Pharm; 2001 Mar; 58(5):363. PubMed ID: 11258166
    [No Abstract]   [Full Text] [Related]  

  • 3. Bivalirudin, a bivalent, thrombin specific anticoagulant as an alternative to heparin in interventional procedures as an alternative to heparin in interventional procedures.
    Chew DP
    Hamostaseologie; 2002 Aug; 22(3):60-6. PubMed ID: 12215763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bivalirudin: a direct thrombin inhibitor.
    Gladwell TD
    Clin Ther; 2002 Jan; 24(1):38-58. PubMed ID: 11833835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDA panel votes against approval for bivalirudin.
    Piña I
    Circulation; 1999 Mar; 99(10):1277. PubMed ID: 10077507
    [No Abstract]   [Full Text] [Related]  

  • 6. Bivalirudin: a new generation antithrombotic drug.
    Scatena R
    Expert Opin Investig Drugs; 2000 May; 9(5):1119-27. PubMed ID: 11060732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved efficacy and less bleeding: further evidence of a unique uncoupling of benefit and risk with bivalirudin.
    White HD
    Am Heart J; 2002 Feb; 143(2):189-92. PubMed ID: 11835018
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacology and clinical use of bivalirudin.
    Sciulli TM; Mauro VF
    Ann Pharmacother; 2002 Jun; 36(6):1028-41. PubMed ID: 12022907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lepirudin for heparin-induced thrombocytopenia.
    Med Lett Drugs Ther; 1998 Sep; 40(1036):94-5. PubMed ID: 9774965
    [No Abstract]   [Full Text] [Related]  

  • 10. Bivalirudin in peripheral interventions.
    Maclean AA; Peña CS; Katzen BT
    Tech Vasc Interv Radiol; 2006 Jun; 9(2):80-3. PubMed ID: 17482105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bivalirudin (Angiomax) use during intracoronary brachytherapy may predispose to acute closure.
    Sharma S; Bhambi B; Nyitray W; Desai K; Davis DL; Sharma G; Shukla P; File C; Ishimori T
    J Cardiovasc Pharmacol Ther; 2003 Mar; 8(1):9-15. PubMed ID: 12652325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Publication policy, informed consent, and the randomized clinical trial.
    Califf RM
    Am Heart J; 2002 Feb; 143(2):187-8. PubMed ID: 11835017
    [No Abstract]   [Full Text] [Related]  

  • 13. Caspofungin acetate, bivalirudin.
    Am J Health Syst Pharm; 2001 Oct; 58(19):1807-9. PubMed ID: 11596694
    [No Abstract]   [Full Text] [Related]  

  • 14. [Bivalirudin as an anticoagulant during percutaneous coronary interventions in acute coronary syndromes: strengths and doubts].
    Savonitto S; Morici N
    Rev Esp Cardiol; 2011 May; 64(5):361-4. PubMed ID: 21482005
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial).
    Lincoff AM; Bittl JA; Kleiman NS; Sarembock IJ; Jackman JD; Mehta S; Tannenbaum MA; Niederman AL; Bachinsky WB; Tift-Mann J; Parker HG; Kereiakes DJ; Harrington RA; Feit F; Maierson ES; Chew DP; Topol EJ;
    Am J Cardiol; 2004 May; 93(9):1092-6. PubMed ID: 15110198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bivalirudin: a review.
    Warkentin TE; Koster A
    Expert Opin Pharmacother; 2005 Jul; 6(8):1349-71. PubMed ID: 16013985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bivalirudin in acute coronary syndromes.
    Sanmartin M
    N Engl J Med; 2007 Mar; 356(10):1069-70; author reply 1070-1. PubMed ID: 17347463
    [No Abstract]   [Full Text] [Related]  

  • 18. Lack of clopidogrel pretreatment effect on the relative efficacy of bivalirudin with provisional glycoprotein IIb/IIIa blockade compared to heparin with routine glycoprotein IIb/IIIa blockade: a REPLACE-2 substudy.
    Saw J; Lincoff AM; DeSmet W; Betriu A; Rutsch W; Wilcox RG; Kleiman NS; Wolski K; Topol EJ;
    J Am Coll Cardiol; 2004 Sep; 44(6):1194-9. PubMed ID: 15364319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Commentary: bivalirudin is a safe and effective anticoagulant in the percutaneous treatment of complex infrainguinal disease.
    Walker CM
    J Endovasc Ther; 2010 Feb; 17(1):37-8. PubMed ID: 20199264
    [No Abstract]   [Full Text] [Related]  

  • 20. Antithrombin deficiency in special clinical syndromes--Part II: cardiovascular surgery.
    Levy JH
    Semin Hematol; 1995 Oct; 32(4 Suppl 2):49-55. PubMed ID: 8821210
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.